title: Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.
authors.affiliation: University of Vienna, Austria.
authors.forename: G
authors.initials: G
authors.lastname: Stingl
authors.forename: E B
authors.initials: EB
authors.lastname: Brŏcker
authors.forename: R
authors.initials: R
authors.lastname: Mertelsmann
authors.forename: K
authors.initials: K
authors.lastname: Wolff
authors.forename: S
authors.initials: S
authors.lastname: Schreiber
authors.forename: E
authors.initials: E
authors.lastname: Kămpgen
authors.forename: A
authors.initials: A
authors.lastname: Schneeberger
authors.forename: W
authors.initials: W
authors.lastname: Dummer
authors.forename: U
authors.initials: U
authors.lastname: Brennscheid
authors.forename: H
authors.initials: H
authors.lastname: Veelken
authors.forename: M L
authors.initials: ML
authors.lastname: Birnstiel
authors.forename: K
authors.initials: K
authors.lastname: Zatloukal
authors.forename: W
authors.initials: W
authors.lastname: Schmidt
authors.forename: G
authors.initials: G
authors.lastname: Maass
authors.forename: E
authors.initials: E
authors.lastname: Wagner
authors.forename: M
authors.initials: M
authors.lastname: Baschle
authors.forename: M
authors.initials: M
authors.lastname: Giese
authors.forename: E R
authors.initials: ER
authors.lastname: Kempe
authors.forename: H A
authors.initials: HA
authors.lastname: Weber
authors.forename: T
authors.initials: T
authors.lastname: Voigt
mesh_terms: D002985:Clinical Protocols; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000235:genetics*; D008545:Melanoma / Q000235:genetics / Q000556:secondary / Q000628:therapy*; D014162:Transfection; D014612:Vaccines / Q000235:genetics*
chemical_list: D007376:Interleukin-2; D014612:Vaccines